Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Nov 18, 2026
TickeronGET DAILY SIGNALS
CLX vs PG: Diverging Paths for These Consumer Staples Leaders

CLX vs PG: Diverging Paths for These Consumer Staples Leaders

Key Takeaways

  • Both CLX and PG operate in consumer staples, but their recent trajectories have diverged sharply, with PG showing stronger relative momentum.
  • PG has trended toward multi-year highs on volume-led organic growth, while CLX has underperformed amid margin strain and a leadership transition.
  • Analyst sentiment is more constructive on PG (consensus near "Moderate Buy") than on CLX (consensus "Hold" with several sell-side ratings).
  • Tickeron AI Verdict: Based on trend consistency, stability, and relative positioning, Tickeron's AI currently favors PG over CLX.
  • For deeper context on each name, explore CLX Major News and CLX Today's Price Move, along with PG Major News and PG Today's Price Move.
  • To see how automated strategies are navigating this and similar setups, explore Trending AI Robots.

Setting the Stage for This Comparison

Consumer staples often serve as a defensive anchor during periods of market uncertainty, yet not all household-products giants perform alike. This stock comparison examines two U.S. bellwethers — The Clorox Company (CLX) and The Procter & Gamble Company (PG) — to help traders and investors assess their relative performance and market positioning. While both companies sell everyday essentials, their recent fundamentals, cost structures, and momentum tell different stories. This analysis is relevant to income-focused investors evaluating dividend durability, as well as momentum and value-oriented traders weighing stability against valuation. By comparing business models, recent developments, and sentiment, readers can better judge which name currently offers the more compelling risk-reward profile.

CLX Overview and Recent Performance

The Clorox Company is a mid-sized consumer packaged goods (CPG) maker known for Clorox bleach, Glad bags, Kingsford charcoal, Hidden Valley, Burt's Bees, and — following its April 2026 acquisition of GOJO Industries — the Purell brand. In recent market activity, CLX has underperformed, trading well below its 52-week range after a sharp decline over the past year and a negative year-to-date return. The stock carries a comparatively low beta, reflecting its defensive profile, yet recent price action has favored sellers. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Sentiment has been pressured by several developments. Fiscal first-quarter results (for the period ended September 2026) showed a sharp headline sales jump of roughly 33%, but much of that increase reflected the GOJO acquisition and the lapping of a prior ERP (enterprise resource planning) inventory disruption. Meanwhile, gross margin narrowed on higher commodity, manufacturing, and logistics costs, and management guided full-year earnings toward the low end of its range amid roughly $240 million in input-cost inflation. A CEO transition — with Linda Rendle stepping down and Fabian Garcia named incoming chief executive — has added an element of uncertainty. An elevated dividend payout ratio has also raised questions about dividend coverage.

PG Overview and Recent Performance

The Procter & Gamble Company is one of the world's largest consumer products companies, with a portfolio spanning Tide, Pampers, Gillette, Crest, and Pantene. Unlike its smaller peer, PG has trended toward multi-year highs in recent weeks, posting a solid positive return over the trailing 52 weeks and a strong year-to-date gain. The stock's stability is reinforced by a lengthy track record of dividend growth, with more than 70 consecutive years of increases.

Recent fundamentals support the constructive tone. In its most recent fiscal quarter, PG delivered its strongest organic sales growth in roughly three years — about 4% — driven primarily by sales volume rather than pricing, a signal that its strategy of moderate price increases is attracting cost-conscious consumers. The company also expanded its health and wellness footprint by agreeing to acquire supplement maker Thorne for roughly $3.8 billion. Investor attention has focused on a scheduled Investor Day, with management expected to outline medium-term strategy. Broadly, sell-side analysts have been raising price targets, and the consensus rating remains more favorable than for CLX.

Head-to-Head Comparison

The most striking contrast between these two names is scale and momentum. PG operates a far larger, more diversified portfolio with global reach, while CLX is a mid-cap operator more concentrated in U.S. household and health-and-hygiene categories. That difference in diversification has translated into divergent recent performance: PG's breadth has helped it sustain stable, volume-driven growth, whereas CLX's turnaround depends more heavily on a single acquisition (GOJO), cost-saving execution, and margin recovery.

Growth drivers also differ. PG's growth is increasingly organic, built on premium brand extensions, buybacks, and disciplined pricing. CLX's near-term growth is more inorganic, leaning on the Purell/GOJO integration and recurring dispenser-based revenue, while its legacy household and cat-litter segments remain under pressure. On risk, CLX faces elevated input-cost inflation, an ERP transition still normalizing, and a dividend payout that currently exceeds earnings — a source of balance-sheet sensitivity. PG also cites commodity and freight headwinds, but its productivity program and larger scale provide greater capacity to absorb them. From a market-sentiment standpoint, PG enjoys firmer analyst support and favorable positioning as a defensive rotation beneficiary, while CLX trades at a lower valuation but with weaker momentum and a more cautious consensus view.

Tickeron AI Verdict

Weighing trend consistency, stability, catalysts, and relative positioning, Tickeron's AI currently leans toward PG over CLX. The preference reflects PG's more persistent uptrend, its volume-led organic growth, a stronger balance sheet with reliable dividend coverage, and more constructive analyst revisions. By contrast, CLX's favorable valuation is offset by margin compression, an elevated payout ratio, and execution risk tied to its CEO transition and acquisition integration. This is a probabilistic assessment rather than a definitive forecast: market conditions can shift, and CLX's lower valuation could become more attractive if its cost and margin recovery gains traction. For now, the observable data favors PG's relative stability and momentum.

Exploring Automated Strategies with Tickeron

In my own research process, I often turn to Tickeron’s AI Trading Bots to test how different automated approaches might handle setups like this one. The platform offers a range of strategies that vary by timeframe, risk level, and asset focus, allowing users to align them with specific goals such as trend following or mean reversion. It is worth reviewing the options to see which ones match individual objectives in the current environment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PG, CLX

PG in +2.97% Uptrend, advancing for three consecutive days on November 16, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PG advanced for three days, in 157 of 350 cases, the price rose further within the following month. The odds of a continued upward trend are 45%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 50-day moving average for PG moved above the 200-day moving average on October 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

The Aroon Indicator entered an Uptrend today. In 90 of 257 cases where PG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 35%.

Bearish Trend Analysis

The 10-day RSI Indicator for PG moved out of overbought territory on November 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 15 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 48%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.

PG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 13 (best 1 - 100 worst), indicating outstanding price growth. PG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 31 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.204) is normal, around the industry mean (21.731). P/E Ratio (24.504) is within average values for comparable stocks, (16.288). PG's Projected Growth (PEG Ratio) (3.813) is slightly higher than the industry average of (1.518). Dividend Yield (0.026) settles around the average of (0.032) among similar stocks. P/S Ratio (4.092) is also within normal values, averaging (1.902).

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 25.17B. The market cap for tickers in the group ranges from 60.48K to 384.17B. PG holds the highest valuation in this group at 384.17B. The lowest valued company is EOSS at 60.48K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was -2%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 19%. SLSN experienced the highest price growth at 80%, while SKIN experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 13%. For the same stocks of the Industry, the average monthly volume growth was 173% and the average quarterly volume growth was 93%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 50
Price Growth Rating: 45
SMR Rating: 73
Profit Risk Rating: 86
Seasonality Score: 34 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of branded consumer packaged goods

Industry HouseholdPersonalCare

Industry
Household Or Personal Care
Address
One Procter and Gamble Plaza
Phone
+1 513 983-1100
Employees
104000
Web
https://us.pg.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.